- Home
- UFI vs ONCY Comparison
UFI vs ONCY Comparison
Compare UFI & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UFI
- ONCY
- Stock Information
- Founded
- UFI 1969
- ONCY 1998
- Country
- UFI United States
- ONCY Canada
- Employees
- UFI N/A
- ONCY N/A
- Industry
- UFI Textiles
- ONCY Pharmaceuticals and Biotechnology
- Sector
- UFI Consumer Discretionary
- ONCY Health Care
- Exchange
- UFI Nasdaq
- ONCY Nasdaq
- Market Cap
- UFI 86.8M
- ONCY 89.7M
- IPO Year
- UFI N/A
- ONCY 1999
- Fundamental
- Price
- UFI $4.51
- ONCY $1.28
- Analyst Decision
- UFI
- ONCY Strong Buy
- Analyst Count
- UFI 0
- ONCY 5
- Target Price
- UFI N/A
- ONCY $5.00
- AVG Volume (30 Days)
- UFI 59.1K
- ONCY 1.2M
- Earning Date
- UFI 10-29-2025
- ONCY 11-11-2025
- Dividend Yield
- UFI N/A
- ONCY N/A
- EPS Growth
- UFI N/A
- ONCY N/A
- EPS
- UFI N/A
- ONCY N/A
- Revenue
- UFI $571,344,000.00
- ONCY N/A
- Revenue This Year
- UFI $12.46
- ONCY N/A
- Revenue Next Year
- UFI $5.64
- ONCY N/A
- P/E Ratio
- UFI N/A
- ONCY N/A
- Revenue Growth
- UFI N/A
- ONCY N/A
- 52 Week Low
- UFI $4.25
- ONCY $0.33
- 52 Week High
- UFI $7.85
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- UFI 51.39
- ONCY 61.30
- Support Level
- UFI $4.29
- ONCY $1.05
- Resistance Level
- UFI $4.63
- ONCY $1.44
- Average True Range (ATR)
- UFI 0.16
- ONCY 0.11
- MACD
- UFI 0.02
- ONCY 0.02
- Stochastic Oscillator
- UFI 67.89
- ONCY 67.35
About UFI Unifi Inc. New
Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.